Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Iambic Therapeutics, Inc.

NASDAQ: IAM · Life Sciences · 3 alerts · CIK 1997038

Share price
$11.85Close, Nov 16
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Iambic Therapeutics, Inc. filings on SEC EDGAR ↗

7:47 PM ET Form 4
Insider Buying

Iambic Therapeutics Director Evan Lockwood Rachlin Buys $11.5M of Stock

Evan Lockwood Rachlin, Director, bought 718,750 shares of Iambic Therapeutics, Inc. at $16.00 a share, worth $11.5M in total on Oct 16, 2026. Shares held after the trade: 2,588,248 (+38.4%).

Value
$11.5M
Shares
718,750
Price
$16.00
Role
Director
Holding change
+38.4%
Trade date
Oct 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.